We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

467 hedge funds and large institutions have $5.28B invested in Bioverativ Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 467 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $21.4M | Put options by funds: $14.1M

Holders
467
Holders Change
+467
Holders Change %
–
% of All Funds
11.62%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
467
Increased
–
Reduced
–
Closed
–
Calls
$21.4M
Puts
$14.1M
Net Calls
+$7.29M
Net Calls Change
+$7.29M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$433M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$429M
3
VH
ValueAct Holdings
California
+$418M
4
Primecap Management
Primecap Management
California
+$381M
5
HM
HealthCor Management
New York
+$246M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fifth Third Bancorp
226
Fifth Third Bancorp
Ohio
$578K +$523K +10,616 New
WIS
227
Wright Investors Service
Connecticut
$539K +$488K +9,905 New
HI
228
Hendershot Investments
Virginia
$527K +$477K +9,682 New
EVM
229
Evelyn V. Moreno
$518K +$469K +9,516 New
RCA
230
Rex Capital Advisors
Rhode Island
$511K +$462K +9,378 New
DADC
231
D.A. Davidson & Co
Montana
$511K +$463K +9,396 New
MCM
232
Mitchell Capital Management
Kansas
$505K +$456K +9,265 New
CONA
233
Capital One National Association
New York
$497K +$450K +9,143 New
TAM
234
Tocqueville Asset Management
New York
$494K +$447K +9,067 New
LS
235
Livforsakringsbolaget Skandia
Sweden
$474K +$429K +8,710 New
Nordea Investment Management
236
Nordea Investment Management
Sweden
$471K +$426K +8,651 New
BII
237
Bainco International Investors
Massachusetts
$470K +$425K +8,630 New
FNBOO
238
First National Bank of Omaha
Nebraska
$465K +$420K +8,527 New
Neuberger Berman Group
239
Neuberger Berman Group
New York
$457K +$413K +8,384 New
BBA
240
Baker Bros. Advisors
New York
$449K +$406K +8,249 New
LD
241
Lipe & Dalton
New York
$447K +$404K +8,212 New
AB
242
Amalgamated Bank
New York
$445K +$403K +8,172 New
SBH
243
Segall Bryant & Hamill
Illinois
$432K +$390K +7,924 New
WAM
244
World Asset Management
Michigan
$430K +$389K +7,895 New
Envestnet Asset Management
245
Envestnet Asset Management
Illinois
$428K +$393K +7,977 New
LIA
246
LS Investment Advisors
Michigan
$423K +$383K +7,767 New
PDN
247
Pensionfund DSM Netherlands
Netherlands
$422K +$382K +7,750 New
OAM
248
Oppenheimer Asset Management
New York
$419K +$380K +7,710 New
BPM
249
Bowling Portfolio Management
Ohio
$414K +$374K +7,600 New
FLPIM
250
F.L. Putnam Investment Management
Massachusetts
$411K +$372K +7,548 New
8 9
10
11 12

BIVV Hedge Fund Activity: Q1 2017 in Review

467 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2017, worth a combined $5.28B.

Buyers outnumbered sellers: 467 funds opened new BIVV positions and 0 closed out — a net gain of 467 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $433M.

  • 467 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $5.28B of Bioverativ Inc. Common Stock stock for Q1 2017.
  • 467 funds opened new Bioverativ Inc. Common Stock positions in Q1 2017 and 0 closed out, a net change of +467 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $433M added.

Based on aggregated 13F filings for Q1 2017.